Published in Hum Mol Genet on August 06, 2015
Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors. Drug Des Devel Ther (2016) 0.80
Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules. J Neurophysiol (2016) 0.75
Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy. Sci Rep (2017) 0.75
Galectin-1 Promotes an M2 Macrophage Response to Polydioxanone Scaffolds. J Biomed Mater Res A (2017) 0.75
Points of control in inflammation. Nature (2002) 10.61
Pax7 is required for the specification of myogenic satellite cells. Cell (2000) 9.88
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med (2007) 7.87
IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell (2004) 6.25
Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol (2010) 5.84
Self-renewal and expansion of single transplanted muscle stem cells. Nature (2008) 5.57
NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science (2000) 5.20
SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol (2003) 4.90
Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev (2008) 4.87
Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol (2010) 4.57
Interleukin-6 and chronic inflammation. Arthritis Res Ther (2006) 3.74
Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther (2007) 3.69
SOCS3 regulates the plasticity of gp130 signaling. Nat Immunol (2003) 3.45
Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab (2008) 3.00
Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest (2007) 2.99
A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet (2002) 2.80
Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem (1995) 2.69
Tissue-specific stem cells: lessons from the skeletal muscle satellite cell. Cell Stem Cell (2012) 2.68
Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol (2007) 2.62
IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) (2012) 2.41
Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J Anat (2002) 2.33
IL-6-induced skeletal muscle atrophy. J Appl Physiol (1985) (2004) 2.30
Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis (2008) 2.20
Mammalian animal models for Duchenne muscular dystrophy. Neuromuscul Disord (2009) 2.15
IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci (2012) 2.15
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest (1997) 2.11
Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J Neurol Sci (1987) 2.03
Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J (2001) 1.96
STAT3 signaling controls satellite cell expansion and skeletal muscle repair. Nat Med (2014) 1.94
Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J Cell Sci (2011) 1.94
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J (2007) 1.92
Inflammatory cell response to acute muscle injury. Med Sci Sports Exerc (1995) 1.88
AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun (2004) 1.75
Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology (2003) 1.74
Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep (2004) 1.66
Sca-1 negatively regulates proliferation and differentiation of muscle cells. Dev Biol (2005) 1.66
Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells. Lab Invest (1995) 1.62
Pre-clinical screening of drugs using the mdx mouse. Neuromuscul Disord (2000) 1.58
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer (1996) 1.57
Inhibition of JAK-STAT signaling stimulates adult satellite cell function. Nat Med (2014) 1.51
Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med (1994) 1.41
Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J Pharmacol Exp Ther (2003) 1.41
Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Exp Neurol (2006) 1.39
Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy. J Neurol Sci (1991) 1.35
Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J (2013) 1.33
Common pathological mechanisms in mouse models for muscular dystrophies. FASEB J (2005) 1.31
The mdx mouse skeletal muscle myopathy: II. Contractile properties. Neuropathol Appl Neurobiol (1989) 1.31
Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse. Muscle Nerve (1995) 1.29
Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling. BMC Genomics (2005) 1.23
Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention. PM R (2009) 1.22
Cytokines in exertion-induced skeletal muscle injury. Mol Cell Biochem (1998) 1.22
Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem Biophys Res Commun (1995) 1.21
Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle Nerve (1996) 1.20
Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise. Muscle Nerve (1998) 1.18
Interleukin 6 as a key regulator of muscle mass during cachexia. Exerc Sport Sci Rev (2010) 1.16
Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol Med (2013) 1.16
Sca-1-expressing nonmyogenic cells contribute to fibrosis in aged skeletal muscle. J Gerontol A Biol Sci Med Sci (2008) 1.12
Impact of ageing on muscle cell regeneration. Ageing Res Rev (2009) 1.08
Enhancing translation: guidelines for standard pre-clinical experiments in mdx mice. Neuromuscul Disord (2011) 1.08
Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB. Aging Cell (2011) 1.06
Chronic treatment with agents that stabilize cytosolic IkappaB-alpha enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch. Neurobiol Dis (2005) 1.06
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone. Exp Neurol (2009) 1.04
NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases. J Mol Med (Berl) (2008) 1.01
Two-tiered hypotheses for Duchenne muscular dystrophy. Cell Mol Life Sci (2008) 1.00
MyoD, myogenin, and desmin-nls-lacZ transgene emphasize the distinct patterns of satellite cell activation in growth and regeneration. Exp Cell Res (1998) 0.98
Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Res (2011) 0.97
Measuring mechanical properties, including isotonic fatigue, of fast and slow MLC/mIgf-1 transgenic skeletal muscle. Ann Biomed Eng (2008) 0.94
First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant. Neuromuscul Disord (2006) 0.92
Interleukin-6 contributes to age-related alteration of cytokine production by macrophages. Mediators Inflamm (2010) 0.92
Steep elevation of blood interleukin-6 (IL-6) associated only with late stages of cachexia in cancer patients. Eur Cytokine Netw (2005) 0.91
Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins. Hum Mol Genet (2003) 0.91
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age. Acta Myol (2011) 0.89
IL-6 impairs myogenic differentiation by downmodulation of p90RSK/eEF2 and mTOR/p70S6K axes, without affecting AKT activity. Biomed Res Int (2014) 0.86
The good, the bad, and the ugly of interleukin-6 signaling. EMBO J (2014) 0.85
Functional and Morphological Improvement of Dystrophic Muscle by Interleukin 6 Receptor Blockade. EBioMedicine (2015) 0.84
Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice. J Pathol (2013) 0.82
Interleukin-6-induced satellite cell proliferation is regulated by induction of the JAK2/STAT3 signalling pathway through cyclin D1 targeting. Cell Prolif (2013) 0.78
Disease course in mdx:utrophin+/- mice: comparison of three mouse models of Duchenne muscular dystrophy. Physiol Rep (2015) 0.78
Muscle side population cells from dystrophic or injured muscle adopt a fibro-adipogenic fate. PLoS One (2013) 0.77
Assessment of murine exercise endurance without the use of a shock grid: an alternative to forced exercise. J Vis Exp (2014) 0.76
ATP regulation of calcium binding in Ca2+-ATPase molecules of the sarcoplasmic reticulum. Ann N Y Acad Sci (2003) 0.76
Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy. Exp Physiol (2014) 0.76